Kendra Packard | IR |
Douglas Fambrough | Co-Founder, CEO, President & Director |
John Green | CFO |
Ralf Rosskamp | Chief Medical Officer |
Jonathan Miller | Evercore ISI |
Mani Foroohar | SVB Leerink |
Stephen Willey | Stifel, Nicolaus & Company |
Irina Margine | Cowen and Company |
Fang-Ke Huang | SunTrust Robinson Humphrey |
Antonio Arce | H.C. Wainwright & Co. |
Keay Nakae | Chardan Capital Markets |
Mayank Mamtani | B. Riley FBR, Inc. |
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2019 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to our host, Kendra Packard, representing Dicerna Pharmaceuticals. Please go ahead.